Streetbeat News

Earnings

PATH

UiPath, Inc. (NYSE:PATH) reported its Q1 financial results, beating analyst estimates for both earnings and sales. Despite this, the stock plummeted 30.33% after-hours due to the announcement of CEO Rob Enslin's resignation and the reappointment of founder Daniel Dines as CEO. The company also provided revenue guidance for Q2 and fiscal year 2025.

Portfolio Pulse from Erica Kollmann

May 29, 2024 | 8:39 pm

NCNO

nCino has provided its financial guidance for Q2 2024 and FY 2025. The company expects Q2 EPS to be between $0.12 and $0.13, below the $0.14 estimate, and revenue between $130.5M and $131.5M, below the $132.23M estimate. For FY 2025, nCino expects EPS between $0.65 and $0.68, above the $0.63 estimate, and revenue between $538.5M and $544.5M, in line with the $541.61M estimate.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 8:36 pm

NCNO

Ncino (NASDAQ:NCNO) reported Q1 adjusted EPS of $0.19, beating the $0.14 estimate by 35.71%. Sales were $128.09M, surpassing the $126.65M estimate by 1.13%. This marks a 171.43% increase in EPS and a 12.68% increase in sales year-over-year.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 8:32 pm

AI

AUUD

BNAI

BNZI

CRM

NCNO

NTNX

OBLG

PATH

PSTG

QMCO

RBT

The article highlights the performance of various Information Technology stocks during Wednesday's after-market session. Notable gainers include C3.ai, Banzai International, and Pure Storage, while significant losers include UiPath, Salesforce, and Nutanix, all of which released their earnings reports.

Portfolio Pulse from Benzinga Insights

May 29, 2024 | 8:30 pm

NTNX

Nutanix has projected its FY24 revenue to be between $2.13 billion and $2.14 billion, slightly below the estimated $2.141 billion.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 8:30 pm

NTNX

Nutanix has projected its Q4 2024 revenue to be between $530 million and $540 million, which is below the estimated $546.068 million.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 8:30 pm

RNA

Avidity Biosciences (NASDAQ:RNA) will present preliminary data from its Phase 1/2 FORTITUDE trial of AOC 1020 for facioscapulohumeral muscular dystrophy at the 31st Annual FSHD Society International Research Congress. The presentation will be held on June 13-14, 2024, in Denver, Colorado.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 8:30 pm

NTNX

Nutanix shares are trading lower following Q3 earnings.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 8:30 pm

AI

C3.ai Inc (NYSE:AI) reported strong Q4 earnings with revenue and EPS beating estimates. The company saw a 20% YoY revenue increase and a significant rise in subscription revenue. C3.ai closed numerous agreements and highlighted growth in its federal segment. The company provided optimistic guidance for Q1 and FY25, expecting continued revenue growth.

Portfolio Pulse from Chris Katje

May 29, 2024 | 8:29 pm

RRGB

Red Robin Gourmet Burgers has reiterated its Fiscal Year 2024 guidance, projecting total revenue between $1.25 billion and $1.275 billion. The company also expects a restaurant-level operating profit of 12.5% to 13.5% and adjusted EBITDA of $60 million to $70 million.

Portfolio Pulse from Benzinga Newsdesk

May 29, 2024 | 8:28 pm